![]() | |
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
Chemical and physical data | |
Formula | C23H31N3O |
Molar mass | 365.521 g·mol−1 |
3D model (JSmol) | |
| |
|
Protodesnitazene is a benzimidazole derivative which has been sold as a designer drug, and has potent opioid effects. It has been identified in Canada, Australia and the United Kingdom, first appearing in early 2025. [1] [2] [3] [4] [5]